MiR-129 regulates growth and invasion by targeting MAL2 in papillary thyroid carcinoma.

@article{Gao2018MiR129RG,
  title={MiR-129 regulates growth and invasion by targeting MAL2 in papillary thyroid carcinoma.},
  author={Xuejun Gao and Zhenyu Chen and Aiqin Li and Xin Zhang and Xia Cai},
  journal={Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  year={2018},
  volume={105},
  pages={
          1072-1078
        }
}

LncRNA ST8SIA6-AS1 Promotes Cholangiocarcinoma Progression by Suppressing the miR-145-5p/MAL2 Axis

It is suggested that the ST8SIA6-AS1/miR-145-5p/MAL2/mal2 axis could enhance Cholangiocarcinoma progression, which might be useful to improve the clinical outcomes of CHOL patients.

Myelin and lymphocyte protein 2 regulates cell proliferation and metastasis through the Notch pathway in prostate adenocarcinoma

MAL2 was found to be upregulated in PRad, and appears to act as a carcinogen in PRAD, and MAL2 appears to regulate PRAD progression through the Notch signaling pathway.

Clinical roles of miR-136-5p and its target metadherin in thyroid carcinoma.

The miR-136-5p/MTDH axis may play a vital role in modulating TC tumorigenesis, providing new insight into possible molecular mechanisms of TC oncogenesis.

Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer

Overexpression of MAL2 correlates with poor prognosis and lower immune infiltrating levels of eosinophils and plasmacytoid dendritic cells in breast cancer and may become a biomarker for breast cancer prognosis.

The role of microRNAs in the pathogenesis of thyroid cancer

FTO modifies the m6A level of MALAT and promotes bladder cancer progression

Fat mass and obesity‐associated protein facilitates the tumorigenesis of bladder cancer through regulating the MALAT/miR‐384/MAL2 axis in m6A RNA modification manner, which ensures the potential of FTO for serving as a diagnostic or prognostic biomarker in bladder cancer.

Overexpression ofMAL2Correlateswith Immune Infiltration and Poor Prognosis in Breast Cancer

Overexpression of MAL2 correlates with poor prognosis and lower immune infiltrating levels of eosinophils and plasmacytoid dendritic cells in breast cancer and may become a biomarker for breast cancer prognosis.

Targeting EZH2 as a novel therapeutic strategy for sorafenib‐resistant thyroid carcinoma

The suppression of EZH2 represents a potential target for thyroid carcinoma therapy and it is proved that the sorafenib resistant cells regained sensitivity for sorAFenib by EZh2 intervention with miR‐124/506 overexpression or EzH2 inhibitor treatment in vitro and in vivo.

MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020

It is found that most micro RNAs regularly expressed in the normal thyroid gland are downregulated in PTC, indicating an important tumor-suppressor action by those microRNAs.

References

SHOWING 1-10 OF 35 REFERENCES

MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2

The results indicated that miR-613 functions as a tumor suppressor in PTC and its suppressive effect is mediated by repressing SphK2 expression.

Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC

The results suggest miR-129-5p functions as an oncogene in LSCC by repressing APC and is a potential therapeutic target for LSCC.

miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer

The discovery of a novel mechanism mediated by microRNA-129 (miR-129) to trigger apoptosis by suppressing a key anti-apoptotic protein, B-cell lymphoma 2 (BCL2) is discovered and it is demonstrated that miR- 129 enhanced the cytotoxic effect of 5-fluorouracil both in vitro and in vivo.

MicroRNA-137 inhibits BMP7 to enhance the epithelial-mesenchymal transition of breast cancer cells

Light is shed on miR-137 as a crucial factor that enhances BC cell EMT and invasiveness, and it is pointed to as a promising innovative therapeutic target for BC treatment.

MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.

Findings suggested that miR-124 was able to suppress cell proliferation, invasion and migration, as well as the EMT process in cervical carcinomas through directly targeting AEG-1.

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells

E ectopic expression of Snail significantly reversed the inhibitory effects ofmiR-137 and miR-34a on OC cell invasion and sphere formation, and suggest that both miR -137 andMiR -34a act as Snail suppressors to negatively regulate EMT, invasive and sphere-forming properties of OC cells.

miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA.